Replay Webinar | COViD-19 in Africa & Yemen : what do seroprevalence surveys tell us?

In this webinar, discover and discuss the results of seroprevalence surveys, determining the proportion of the population having developed anti-SARS-CoV-2 antibodies, in Cameroon, DRC, Yemen, Mali, Sudan, Kenya and Niger conducted by Epicentre and INRB/IRD. This is also an opportunity to review the different tests used, the questions they raise, and the operational impact of these studies on public health policies in the countries concerned.

With

• Salha Issoufou, Director of operations at MSF WaCA
• Etienne Gignoux, Epidemiologist at Epicentre
• Céline Langendorf, Epicentre Laboratory coordinator
• Antoine Nkuba, MD- MPH INRB Kinshasa, DRC & IRD/Montpellier, France
• Prof. Pierre Ongolo-Zongo, vice-Chairman of the of the National Consultative Group on Immunization in Cameroon
• Yap Boum, Representative of Epicentre Africa